Yeastract
Please fill in here our
user satisfaction survey
Thank you!
YEASTRACT+ INESC-ID IST IBB
Home > Go Back > View Contact/Credits     Tutorial     Help

 

Back to top top

Regulation Reference(s)

The Yeastract team, is actively curating each regulation evidence code, association type and environmental condition.
Transcription
Factor		 Target
ORF/Genes		 References Evidence
Code		 Evidence
Experiment		 Association
Type		 Strain Environmental
Condition
Rph1p YAL067C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YAL065C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR090C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YBR091C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR092C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR093C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR094W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR096W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR101C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR105C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR113W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YBR115C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR120C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR122C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR126C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YBR128C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD
PubMed external link Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167 Indirect RT-PCR - wt vs TF overexpression Negative JKM179 YPD + methyl-methane sulphonate (MMS)
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR129C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR132C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YBR139W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR141C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR142W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR145W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR146W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR147W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR149W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR150C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR152W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YBR155W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR156C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR157C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR158W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR159W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YBR162W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR166C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YBR175W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR176W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR179C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR180W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR181C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR182C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR183W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR185C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR186W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR189W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR191W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR198C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR201W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YBR204C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR207W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YBR208C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR214W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR222C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR238C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR240C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR241C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR244W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YBR245C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YBR247C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR248C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR251W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR256C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR264C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YBR265W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR267W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR269C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR270C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR285W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YBR287W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR288C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YBR295W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR297W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YBR298C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YBR299W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; log phase cells harvested after 3h of growth
YCL065W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YCL064C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL063W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YCL061C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL059C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL058C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YCL054W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL049C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCL043C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL040W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL039W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL038C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCL037C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL036W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL033C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCL030C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL027W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCL025C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YCL002C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YCR003W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR006C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YCR007C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR016W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR020C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR024C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCR025C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR026C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR031C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR043C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR046C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCR047C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR054C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR057C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR061W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCR065W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR068W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCR072C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR073C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR075C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR083W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCR086W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCR098C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR099C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR100C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR101C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR102C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCR105W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YCR106W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YCR107W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YDL248W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YDL247W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL246C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL244W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL243C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL241W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL240W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YDL238C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL234C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL232W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL230W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDL229W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL227C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL226C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDL222C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDL218W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL215C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL211C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL210W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL209C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YDL206W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDL202W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL201W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL199C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDL198C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL194W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YDL193W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDL183C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL181W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL180W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL179W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL176W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDL174C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL173W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL171C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YDL169C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL167C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL164C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL161W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL159W-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDL156W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YDL154W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL153C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL150W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL149W PubMed external link Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD
PubMed external link Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167 Indirect RT-PCR - wt vs TF overexpression Negative JKM179 YPD + methyl-methane sulphonate (MMS)
YDL148C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL143W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDL139C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL137W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL133W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL130W-A PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL130W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL129W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL124W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL123W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL112W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL110C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL101C PubMed external link Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197 Indirect RT-PCR - wt vs TF overexpression Negative BY4741 YPD + methyl-methane sulphonate (MMS)
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL095W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL086W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL085W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL083C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL082W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL081C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL075W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL072C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL070W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL069C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL067C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL066W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL063C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL060W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL049C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL048C PubMed external link Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197 Direct ChIP N/A BY4741 YPD
Indirect RT-PCR - wt vs TF overexpression Negative BY4741 YPD + methyl-methane sulphonate (MMS)
YDL044C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL042C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL040C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDL039C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YDL037C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL036C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL035C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL031W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL027C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDL024C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL021W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDL018C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL014W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL010W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL009C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL004W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL003W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR001C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR004W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDR009W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR012W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR016C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR019C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR021W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR022C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR025W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR027C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YDR031W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR032C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR033W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR034W-B PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR035W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR043C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR044W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR047W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR058C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR059C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR060W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR064W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR067C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YDR068W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YDR069C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR070C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR078C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR079W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR083W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR084C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YDR086C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR087C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR091C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR100W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR101C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR106W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YDR107C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR115W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YDR116C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR118W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR120C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR122W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR123C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; log phase cells harvested after 3h of growth
YDR124W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YDR126W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR133C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YDR145W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR148C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR151C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YDR152W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YDR154C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YDR155C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR156W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YDR157W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YDR158W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR161W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR165W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR168W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR173C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR175C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR178W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR183W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDR188W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDR194C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR197W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR201W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR204W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR207C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR209C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR211W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR213W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR214W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR216W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YDR222W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR226W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR228C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR233C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR236C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR237W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR242W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR245W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YDR248C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR249C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR252W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR255C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR259C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR261C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR268W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR275W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR277C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR279W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR281C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YDR282C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YDR284C PubMed external link Oshiro J et al., J Biol Chem, 2003 Aug 22;278(34):31495-503Oshiro J et al., J Biol Chem, 2003 Aug 22;278(34):31495-503 Indirect lacZ - wt vs TF mutant Negative S288c cells grown in complete synthetic medium containing 2% glucose with 50 µM inositol and harvested in the stationary phase
YDR285W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR286C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR292C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR298C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR299W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR312W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR313C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YDR315C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR316W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR317W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR320C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YDR320C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR322W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR322C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR324C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR330W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR336W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR337W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR340W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR342C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YDR343C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR345C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR347W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR354W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR358W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR361C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR363W-A PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDR373W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR374C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YDR377W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR379C-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR380W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR382W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR384C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR385W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR389W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR398W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR403W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR405W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR412W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR418W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR427W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR446W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDR447C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR448W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR449C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR450W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDR451C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR461W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YDR462W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR465C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR470C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR471W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR472W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDR473C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YDR480W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YDR484W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YDR486C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR490C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR493W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR494W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR496C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR497C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR503C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR506C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR507C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR508C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR511W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YDR514C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR523C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YDR525W-A PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR528W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR529C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR533C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR539W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR540C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR541C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL066W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YEL065W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL064C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL060C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YEL059W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL055C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL054C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL050C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL048C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL040W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL030W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; log phase cells harvested after 3h of growth
YEL029C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL024W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YEL013W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YEL012W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YEL009C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER001W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER002W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER006W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER013W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YER016W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER024W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER028C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER029C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YER036C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YER037W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER039C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YER039C-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER042W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER043C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER044C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YER046W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER047C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YER052C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER053C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER055C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER056C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER057C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER058W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER062C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER065C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER069W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER070W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER073W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER074W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER081W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YER082C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER087W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER088C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YER090W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER093C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER095W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER096W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER101C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER102W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER110C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER111C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER115C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER119C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER124C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER126C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER127W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER128W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER131W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER137C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER142C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197 Indirect RT-PCR - wt vs TF overexpression Negative BY4741 YPD + methyl-methane sulphonate (MMS)
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER150W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER153C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER154W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER156C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YER158C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YER163C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YER167W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER169W PubMed external link Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167 Indirect Western blot - wt vs TF mutant Positive JKM179 YPD + methyl-methane sulphonate (MMS)
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER170W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER175C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER177W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YER184C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER185W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YER188W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YFL062W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL061W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL059W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YFL056C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL055W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YFL051C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YFL046W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL040W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YFL034W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YFL031W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL030W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YFL028C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL023W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL022C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL021W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL018C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL017W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL015C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL014W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL010W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL008W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFL003C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YFR007W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR017C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR024C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YFR030W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR031C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR033C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR046C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR049W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR050C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR052W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YFR055W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YFR057W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL263W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; log phase cells harvested after 3h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL262W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL259W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL258W-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YGL255W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL250W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YGL245W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGL242C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL238W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YGL236C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL234W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL229C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL227W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YGL225W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL224C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL223C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YGL222C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGL209W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL208W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL202W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL196W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL191W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL189C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL188C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL187C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL184C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL183C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL180W PubMed external link Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL179C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL175C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGL171W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL169W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL163C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL162W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL158W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL157W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL156W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL153W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGL148W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YGL147C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL143C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL135W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL127C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL123W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL121C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL120C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL119W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL117W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL116W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL112C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGL111W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL105W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGL104C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL103W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL099W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL096W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL094C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL081W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YGL078C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL076C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL071W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGL068W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL064C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL063W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL062W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL058W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL056C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL047W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL045W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL040C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL038C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL035C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGL033W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL032C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGL031C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL030W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL029W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL028C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL010W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL009C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGL003C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGR012W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGR019W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR021W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR030C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR034W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR036C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YGR039W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGR040W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGR043C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YGR044C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR046W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGR052W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YGR053C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR054W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR062C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR064W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YGR066C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR081C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR082W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR084C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR088W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD 30.C
YGR090W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR096W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR101W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YGR103W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR109C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR112W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR116W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGR123C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR126W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR128C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR131W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR132C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR138C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR142W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR145W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR146C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YGR149W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR150C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YGR153W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR155W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR159C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR162W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR165W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR166W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR169C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR177C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YGR182C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR183C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR188C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR189C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR194C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR197C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR200C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR201C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR209C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR211W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGR213C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR214W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR221C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR222W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR225W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR226C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YGR227W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR231C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR232W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR234W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR236C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YGR238C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR239C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR243W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGR244C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR245C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR255C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YGR256W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR258C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YGR260W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR261C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGR267C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR269W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR270W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YGR271C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR280C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR287C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR289C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YHL048W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; log phase cells harvested after 3h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL043W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YHL042W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL040C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL039W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL038C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL035C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHL033C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL030W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHL028W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL020C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YHL018W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YHL015W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL014C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL012W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL010C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHL008C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YHL004W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL002W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YHR001W-A PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR004C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YHR006W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR008C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR011W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR016C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR018C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR024C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YHR037W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR038W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR039C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR048W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YHR049W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR049C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YHR050W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR051W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR052W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR057C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YHR059W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR061C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR065C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR066W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR069C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR070W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR071W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR075C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YHR079C-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR080C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YHR085W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR088W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR089C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR092C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR094C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR096C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR104W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR106W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR110W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR112C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR113W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR116W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR118C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YHR132W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR135C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YHR136C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR137W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR140W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR141C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR142W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR143W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR146W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YHR147C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR148W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR154W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR155W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YHR169W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR170W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR171W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD
PubMed external link Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 Indirect RT-PCR - wt vs TF mutant Negative S288c mid-log phase - YPD
PubMed external link Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167 Indirect RT-PCR - wt vs TF overexpression Negative JKM179 YPD + methyl-methane sulphonate (MMS)
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YHR176W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR196W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR197W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR200W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YHR203C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR207C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YHR209W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR215W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR216W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHR219W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL169C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL165C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL164C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL156W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YIL148W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YIL146C PubMed external link Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD
YIL142W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YIL140W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL134W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YIL133C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL127C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL124W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL123W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL117C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL116W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL108W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL107C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIL104C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL096C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL093C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL091C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL089W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YIL087C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YIL085C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YIL073C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YIL072W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YIL070C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL069C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL067C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL064W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL063C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL056W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL055C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIL051C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL049W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YIL042C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YIL037C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL034C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL026C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YIL023C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL019W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL018W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL014C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIL011W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL010W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIL009W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL006W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR007W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIR008C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YIR009W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR010W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YIR017C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR021W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR023W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YIR026C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR027C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR028W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIR032C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YIR033W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR034C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR036C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIR037W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIR038C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIR039C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR041W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIR042C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL217W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL213W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL212C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL200C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YJL199C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL190C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL187C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL185C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL184W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL183W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL181W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL180C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL177W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL173C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL172W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL171C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL170C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL166W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL165C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL164C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YJL163C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL161W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL160C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL158C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL155C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL153C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL148W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL144W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL143W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YJL137C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL132W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL131C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL126W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YJL125C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL116C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL115W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL109C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL108C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL107C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL105W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YJL102W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL096W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL026W PubMed external link Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197 Direct ChIP N/A BY4741 YPD
Indirect RT-PCR - wt vs TF overexpression Negative BY4741 YPD + methyl-methane sulphonate (MMS)
YJL016W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL011C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL010C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR002W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR010W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR016C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR025C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJR034W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJR041C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR044C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YJR045C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YJR046W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YJR047C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR048W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR054W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR055W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR070C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR077C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR078W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR096W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJR100C PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YJR101W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR102C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YJR104C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJR109C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR112W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR113C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR115W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR117W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR120W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR121W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR122W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJR123W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR129C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR130C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR132W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR137C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR141W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YJR144W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR145C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR147W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR150C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR151C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR152W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR153W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YJR154W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR155W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJR156C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJR159W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL221W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL219W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL218C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL217W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL211C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL208W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL204W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL195W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL194C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL193C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL192C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL191W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL188C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YKL187C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YKL185W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YKL181W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL180W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL178C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL172W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL169C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YKL164C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL163W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL162C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL161C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL159C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL155C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL151C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL150W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL149C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YKL143W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL141W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL138C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL132C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YKL125W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL120W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YKL107W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL106W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL105C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YKL103C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL102C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL101W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL099C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL096W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL092C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL089W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL087C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL085W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL084W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKL082C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL078W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL073W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YKL072W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YKL071W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; log phase cells harvested after 3h of growth
YKL068W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YKL067W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL066W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL065C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL062W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YKL058W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YKL050C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL043W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YKL037W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL033W-A PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL033W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YKL021C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL016C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL013C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL009W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL006W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKL001C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR001C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YKR003W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKR006C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR007W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR011C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YKR013W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR020W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR026C PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YKR034W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR041W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR042W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR051W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR056W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR060W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR061W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YKR062W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YKR065C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKR075C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR076W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKR077W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR081C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR085C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR092C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR093W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YKR098C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YKR102W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YKR106W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL063C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLL060C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YLL058W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YLL053C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YLL050C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL046C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL045C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL041C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL039C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLL034C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL033W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YLL028W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL024C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL018C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YLL015W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YLL011W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL009C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLL008W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR001C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR002C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR003C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR008C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR009W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR010C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR019W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR026C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YLR029C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR030W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; log phase cells harvested after 3h of growth
YLR031W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YLR038C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR042C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR047C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YLR048W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR049C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR050C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR054C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YLR060W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YLR061W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR062C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR063W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR068W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR069C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR072W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR073C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR074C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR075W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR079W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR080W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR082C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YLR084C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR085C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YLR092W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YLR099C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YLR106C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR108C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR109W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR115W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YLR118C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR121C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR124W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR129W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR130C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR135W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR136C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR139C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR140W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR146C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR150W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR154C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YLR155C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR156W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR157C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR158C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR159W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR160C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR161W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR164W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR167W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR173W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR174W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR175W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR178C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR179C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR183C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR187W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR194C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR195C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YLR196W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR197W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR198C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR203C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR205C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR214W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR215C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR216C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR218C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR222C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR231C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR237W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR242C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR244C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR246W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR248W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR251W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR253W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR255C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR258W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR259C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR264W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR267W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YLR270W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR274W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YLR276C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR286C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR290C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR294C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR295C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR297W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR299W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR300W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR302C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YLR304C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR306W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR308W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YLR309C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR312C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR312W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR313C PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR315W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR324W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR326W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR327C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR336C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR338W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YLR339C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YLR340W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR341W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YLR342W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR345W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR346C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR348C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR354C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR355C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR356W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR359W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YLR367W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR370C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR376C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR377C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR383W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR387C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR395C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR397C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR400W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR401C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR406C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR409C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR411W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR413W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR414C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR416C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YLR423C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YLR427W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YLR431C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR438W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YLR439W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR441C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR443W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR446W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR449W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YLR456W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YML130C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML129C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YML125C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML121W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML110C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YML101C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YML100W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML093W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML091C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML090W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YML087C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YML086C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML085C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YML082W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML081C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML080W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML073C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML063W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML056C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML050W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML043C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML038C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML037C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YML035C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YML032C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML028W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YML027W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML026C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML022W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YML009C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YML001W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR002W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR011W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR014W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR016C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR019W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR023C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR024W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR030W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR032W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR033W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR034C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR040W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YMR049C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR058W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR062C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR068W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR069W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR070W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YMR071C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR074C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR076C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR081C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YMR083W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR084W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR085W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR093W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR094W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR095C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR096W PubMed external link Weiner A et al., PLoS Biol, 2012;10(7):e1001369Weiner A et al., PLoS Biol, 2012;10(7):e1001369 Indirect Microarray analysis - wt vs TF mutant Positive S288c Diamide exposure-45min
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR100W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR101C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR105C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR107W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YMR108W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR116C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR118C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR120C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YMR122W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR125W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR128W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR133W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR136W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR142C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR143W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR144W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR147W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR148W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR152W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR157C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR159C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YMR160W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YMR163C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR165C PubMed external link Pascual F et al., J Biol Chem, 2013 Dec 13;288(50):35781-92Pascual F et al., J Biol Chem, 2013 Dec 13;288(50):35781-92 Indirect lacZ - wt vs TF mutant Positive S288c YEPD medium or SC medium supp. with 2% glucose
YMR170C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR171C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR173W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR173W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR174C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR175W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR179W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR181C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR182C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR184W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR186W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR188C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR189W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YMR192W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR193W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR193C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR195W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YMR199W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR200W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR204C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR206W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR215W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR217W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR220W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR222C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YMR227C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR228W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR229C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR236W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR238W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR239C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR244W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YMR246W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR250W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR251W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR256C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR259C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR267W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR268C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YMR269W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR271C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR274C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR277W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR290C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR294W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR295C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR297W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YMR299C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YMR304C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR305C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR307W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR309C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR310C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR315W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR316W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR317W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YMR321C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR322C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YMR323W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL333W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL332W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNL327W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL326C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNL317W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL315C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL312W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL311C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL308C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL306W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL305C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNL302C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL301C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL300W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL294C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL293W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL292W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL290W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNL289W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL287W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNL281W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL279W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL278W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL274C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL269W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNL257C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YNL256W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL252C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL248C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL241C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL234W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL222W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL214W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNL209W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL208W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL202W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL200C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL196C PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YNL194C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YNL193W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YNL192W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL191W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNL185C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL184C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNL182C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL178W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL175C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL167C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL163C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL162W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL160W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL155W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL149C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNL148C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL145W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNL143C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL141W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL137C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL134C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL132W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL129W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL125C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL124W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL122C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL120C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNL119W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL118C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YNL117W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL115C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL112W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL110C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL104C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL099C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL093W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YNL092W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL078W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL077W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL076W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNL075W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL069C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL067W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL065W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNL064C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNL062C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL061W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL058C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL052W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL050C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL044W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL037C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL036W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL034W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL031C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL030W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL029C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNL027W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNL024C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL022C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL015W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNL012W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL011C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YNL007C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNL002C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR006W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNR009W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR010W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR012W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR014W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR017W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR022C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNR024W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR029C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR030W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNR034W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNR035C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR037C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNR038W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YNR040W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNR044W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNR047W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR053C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR054C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR057C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR058W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR065C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR066C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR067C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR068C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR069C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNR070W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YNR071C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YNR073C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL165C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL163W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YOL160W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL159C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL158C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL157C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL156W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL155C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL154W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL152W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL151W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL150C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOL147C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOL146W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL144W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL140W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL135C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL131W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL129W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL128C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOL124C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL121C PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YOL120C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL119C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL118C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOL117W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOL115W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL113W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL109W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL105C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YOL104C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOL101C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL097C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOL093W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL091W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL090W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL086W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL086C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL084W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL083W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL082W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL080C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL078W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YOL077W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL077C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL076W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOL073C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOL071W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL064C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL060C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL059W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL058W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL056W PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Negative S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YOL051W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL048C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL047C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOL041C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL040C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL039W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL038W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL036W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL031C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YOL021C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL017W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL016C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL014W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL010W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL007C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR001W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR004W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR006C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR008C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR015W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR017W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR020C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR026W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR027W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR028C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR038C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR040W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR043W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR044W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR056C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR062C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR063W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR064C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YOR065W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR066W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YOR078W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR091W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR095C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR096W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR100C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR103C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR104W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR105W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR114W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR119C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR121C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR122C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR126C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR130C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR134W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR136W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR137C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR142W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR151C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YOR152C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR153W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR155C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR158W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR168W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR173W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR177C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR182C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YOR185C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR195W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR197W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR198C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR202W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR206W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR208W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR209C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR212W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR215C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOR217W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR218C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR220W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR228C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOR230W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR243C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR247W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR248W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR254C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR256C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR260W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR264W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR271C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR272W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR273C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR285W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR287C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR289W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR291W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR292C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOR293W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR297C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOR298W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR298C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR302W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR303W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR306C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOR309C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR310C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR313C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR314W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR315W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR316C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR317W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR324C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR326W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR327C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR330C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YOR333C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOR334W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YOR337W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR338W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR340C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR341W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR348C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR349W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR354C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR361C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR365C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR367W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR369C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR374W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR377W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YOR378W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YOR382W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR383C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YOR385W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR386W PubMed external link Jang YK et al., Mol Cell Biol, 1999 Nov;19(11):7630-8Jang YK et al., Mol Cell Biol, 1999 Nov;19(11):7630-8 Indirect lacZ - wt vs TF mutant Negative S288c methylmethanesulphonate presence
PubMed external link Liang CY et al., Nucleic Acids Res, 2011 May;39(10):4151-65Liang CY et al., Nucleic Acids Res, 2011 May;39(10):4151-65 Direct ChIP N/A S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197Li F et al., Nucleic Acids Res, 2017 May 19;45(9):5183-5197 Direct ChIP N/A BY4741 YPD
Indirect RT-PCR - wt vs TF overexpression Negative BY4741 YPD + methyl-methane sulphonate (MMS)
YPL277C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YPL274W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL273W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL272C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL271W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL269W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YPL267W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL266W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL264C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL259C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL257W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPL256C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL255W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL253C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YPL251W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YPL250C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL249C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YPL247C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL246C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPL245W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL241C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL240C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL223C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YPL221W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL220W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL217C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL215W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL211W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL206C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPL203W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL200W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YPL193W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL192C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YPL188W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL186C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YPL183W-A PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPL183C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL182C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL179W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL176C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL174C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YPL173W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL172C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPL171C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL170W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL169C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Negative S288c Addition of 50mM menadione or ethanol
YPL166W PubMed external link Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD
PubMed external link Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 Indirect RT-PCR - wt vs TF mutant Negative S288c mid-log phase - YPD
PubMed external link Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167 Indirect RT-PCR - wt vs TF overexpression Negative JKM179 YPD + methyl-methane sulphonate (MMS)
YPL165C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPL163C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL160W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL158C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL157W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL154C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPL153C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL148C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL146C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL144W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPL134C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPL132W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL131W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL126W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL124W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL123C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPL122C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL119C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPL113C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL104W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL093W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL091W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL090C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL088W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL087W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPL086C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL081W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL078C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL075W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL072W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL068C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL066W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL065W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL063W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL061W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL059W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPL058C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL057C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YPL054W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPL043W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL041C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL040C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL039W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YPL033C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL032C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL029W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL019C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPL016W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPL015C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YPL014W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
YPL013C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPL012W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR002W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR002C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR004C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPR007C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR009W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPR010C PubMed external link Cahyani I et al., Mol Cell Biol, 2015;():Cahyani I et al., Mol Cell Biol, 2015;(): Indirect RT-PCR - wt vs TF mutant Negative S288c exponential
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR011C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPR012W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR015C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR020W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR021C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR026W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YPR037C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPR038W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPR046W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR047W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR048W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR049C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR061C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR067W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR069C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPR078C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR083W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR095C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YPR098C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR106W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR110C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR111W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR112C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR117W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR123C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR124W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR127W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR132W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR138C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YPR140W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR143W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR144C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR145W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR151C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YPR154W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR156C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR158W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR159W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPR160W PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YPR167C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR172W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YPR174C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR175W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR176C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YPR184W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR186C PubMed external link Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64Schroeder EA et al., Cell Metab, 2013 Jun 4;17(6):954-64 Indirect Microarray analysis - wt vs TF mutant Positive S288c Addition of 50mM menadione or ethanol
YPR191W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR192W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR193C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR194C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCA0001W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCG0010W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNCM0030W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL062W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL061W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL060W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YAL059W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL055W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL049C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YAL046C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL044C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL043C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YAL039C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL037W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YAL030W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YAL025C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL023C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YAL021C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL008W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YAL007C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAR002W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YAR007C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAR008W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAR020C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAR035W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAR042W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YAR068W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD 30.C
YAR071W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAR073W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YBL111C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL107C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBL103C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL102W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL100C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL099W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL098W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YBL092W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL091C-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBL085W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL078C PubMed external link Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55Bernard A et al., Curr Biol, 2015 Mar 2;25(5):546-55 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD
PubMed external link Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122Bernard A et al., Autophagy, 2015 Nov 2;11(11):2114-2122 Indirect RT-PCR - wt vs TF mutant Negative S288c mid-log phase - YPD
PubMed external link Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167Eapen VV et al., Proc Natl Acad Sci U S A, 2017 Feb 14;114(7):E1158-E1167 Indirect Western blot - wt vs TF mutant Negative JKM179 YPD + methyl-methane sulphonate (MMS)
Indirect RT-PCR - wt vs TF overexpression Negative JKM179 YPD + methyl-methane sulphonate (MMS)
YBL075C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL072C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL069W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL065W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
YBL064C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBL063W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL059W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YBL054W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL051C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL045C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL043W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL040C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL039C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL030C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL028C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL027W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL024W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL023C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YBL016W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL013W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL005W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBL004W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL003C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL002W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBL001C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR003W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR004C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR005W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR006W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR012C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR013C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR018C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR023C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR024W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR031W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR032W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YBR033W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YBR035C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR036C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YBR038W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR039W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR040W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR046C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR047W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR048W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR050C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR052C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR053C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR054W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR056W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YBR057C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YBR067C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR069C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR071W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR072W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect RT-PCR - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR073W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR079C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR083W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR084W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR084C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR088C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL089W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL088W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL085W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL079C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL078C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL074C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL070C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL069C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL068C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL067W PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c N/A
PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
YJL066C PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL062W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL060W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL052W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL050W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL045W PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YJL034W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL033W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR182C-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YBR230W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YCL012C PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YCR075W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCN0005C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER053C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YER138C PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
YNCO0025W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGL188C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNCJ0004C PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR146C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YGR169C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YHL015W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YNCM0031W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YHR050W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL133C-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDL131W PubMed external link Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77Reimand J et al., Nucleic Acids Res, 2010 Aug;38(14):4768-77 Indirect Microarray analysis - wt vs TF mutant Positive S288c YPD medium; mid-log phase
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR264C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCC0012C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCN0013W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YLR342W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCJ0020W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YMR001C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YML100W-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YNL277W-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YNCA0003W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNL042W-B PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL155W-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YIL170W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOL038C-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YOR032W-A PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YNCD0030W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YOR381W-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YPL189C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCN0019C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YAL016C-B PubMed external link Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078Nordberg N et al., PLoS One, 2014 Jul 7;9(7):e95078 Indirect Microarray analysis - wt vs TF mutant Positive S288c Grown in YPD media; PDS phase cells harvested after 12h of growth
YBR196C-B PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR056W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YJL047C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNCJ0030W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCL0003W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCO0027C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNCC0006C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNCL0048W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCJ0007C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCP0015C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCK0020C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCC0003C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCL0046W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCN0018W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNCM0005C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCL0042C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCL0043C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCL0006W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YNCD0002C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNCE0002W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCP0014C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCC0004C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR210C-D PubMed external link Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 Direct Chip-on-chip N/A S288c SC medium; mid-log phase
Direct Chip-on-chip N/A S288c N/A
YGR161W-C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YGR174W-A PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YNCE0027C PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YNCB0001W PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YNCJ0019C PubMed external link Lee TI et al., Science, 2002 Oct 25;298(5594):799-804Lee TI et al., Science, 2002 Oct 25;298(5594):799-804 Direct Chip-on-chip N/A S288c YPD medium; mid-log phase
YNCE0007C PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCE0024W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNCE0017W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YNL097C-B PubMed external link Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62Liang CY et al., Mol Biol Cell, 2013 Oct;24(20):3251-62 Indirect Microarray analysis - wt vs TF mutant Negative S288c YPD 30.C
YDR119W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YNCL0018W PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YBR201C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase
YCL048W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDL022C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YDR461C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Negative BY4741 YPD medium; exponential phase
YIL156W-B PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YLR146W-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR010C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
YPR145C-A PubMed external link Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373Shu WJ et al., Nucleic Acids Res, 2020 Sep 4;48(15):8360-8373 Indirect RNA-seq - wt vs TF overexpression Positive BY4741 YPD medium; exponential phase treated with 100 nM Rapamycin for 2 h
w3c xhtml validator w3c css validator